Treatment of RA with rituximab leads to selected peripheral B-cell depletion with minimal effect on immunoglobulins

被引:0
|
作者
Szechinski, J
Szczepanski, L
Filipowicz-Sosnowska, A
Stahj, HD
Edwards, JCW
Close, DR
Stevens, R
Shaw, TW
机构
[1] Med Acad Wroclaw, Dept Rheumatol, Wroclaw, Poland
[2] Med Univ Lublin, Dept Rheumatol, Lublin, Poland
[3] Med Univ Warsaw, Dept Rheumatol, Warsaw, Poland
[4] Zentrum Therapiestudien, Dept Rheumatol, Leipzig, Germany
[5] UCL, Ctr Rheumatol, London, England
[6] Roche Prod Ltd, Pharma Dev, Welwyn Garden City AL7 3AY, Herts, England
[7] Roche Prod Ltd, Pharma Dept, Nutley, NJ USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:171 / 171
页数:1
相关论文
共 50 条
  • [1] B-CELL DEPLETION THERAPY WITH RITUXIMAB IN RA: UCLH/UCL 20 YEARS OF EXPERIENCE
    Norris-Grey, Caitlin M.
    Moore, Samantha
    Cambridge, Geraldine
    Reedy, Venkat
    Leandro, Maria
    [J]. RHEUMATOLOGY, 2020, 59 : 106 - +
  • [2] B-cell depletion/repletion patterns, immunoglobulins, and infection rates with repeated rituximab courses.
    Genovese, M.
    Emery, P.
    Ruderman, E.
    Keystone, E.
    Boling, E.
    van Vollenhoven, R. F.
    McCabe, D.
    Magrini, F.
    Agarwal, S.
    Cooper, S.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S779 - S780
  • [3] Rituximab: novel B-cell depletion therapy for the treatment of rheumatoid arthritis
    Dass, Shouvik
    Vital, Edward M.
    Emery, Paul
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (18) : 2559 - 2570
  • [4] Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia
    Stasi, R
    Brunetti, M
    Stipa, E
    Amadori, S
    [J]. BLOOD, 2004, 103 (12) : 4424 - 4428
  • [5] Effects of peripheral B-cell depletion
    Bar-Or, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S38 - S38
  • [6] Minimal effect of rituximab dose on duration of B cell depletion in neuromyelitis optica
    Havla, J.
    Pellkofer, H.
    Schuh, E.
    Gerdes, L.
    Meinl, I.
    Hohlfeld, R.
    Kuempfel, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 492 - 492
  • [7] PROLONGED B-CELL DEPLETION IN MuSK MYASTHENIA GRAVIS FOLLOWING RITUXIMAB TREATMENT
    Yi, John S.
    DeCroos, Emily C.
    Sanders, Donald B.
    Weinhold, Kent J.
    Guptill, Jeffrey T.
    [J]. MUSCLE & NERVE, 2013, 48 (06) : 992 - 993
  • [8] B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis
    Jacob M van Laar
    [J]. Arthritis Research & Therapy, 12
  • [9] B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis
    van Laar, Jacob M.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2010, 12 (02)
  • [10] B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia
    Zaja, F
    Iacona, I
    Masolini, P
    Russo, D
    Sperotto, A
    Prosdocimo, S
    Patriarca, F
    Regazzi, M
    Baccarani, M
    Fanin, R
    de Vita, S
    [J]. HAEMATOLOGICA, 2002, 87 (02) : 189 - 195